Company Profile
Adverum Biotechnologies Stock Price, News & Analysis
- Ticker:
- ADVM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for ADVM.
Company overview
Business overview
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease. Its story centers on whether durable ocular gene therapy can create value in a difficult but high-unmet-need space.
Geographic Base and Sector Classification
Adverum is headquartered in the United States and listed on NASDAQ. It sits in gene therapy and ophthalmology biotechnology.
Business Model Characteristics
The company depends on clinical and safety data, vector and manufacturing execution, and the ability to keep a narrow ocular pipeline funded. Investors watch readouts and strategic progress closely.
Position Within the Biotechnology Landscape
Adverum occupies a specialized ophthalmic gene-therapy niche within biotech. The stock is catalyst-sensitive because the platform still needs to prove a strong and durable safety-efficacy balance.
Future catalysts
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Adverum Biotechnologies do?
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease. Its story centers on whether durable ocular gene therapy can create value in a difficult but high-unmet-need space.
On which exchange is ADVM stock listed?
Adverum Biotechnologies (ADVM) is associated with NASDAQ, United States, Biopharma.
What is Adverum?
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease.
Which conditions is Adverum Biotechnologies targeting with Adverum?
Adverum Biotechnologies is associated with ophthalmology based on its company overview and current catalyst commentary.
What is Biotechnologies?
Adverum Biotechnologies is a gene-therapy company focused on ophthalmology and retinal disease.